For 50 years, our division has been dedicated to excellence in patient care, training, and research in pediatric infectious diseases. Our mission is to foster knowledge through research, teaching, and training of physicians and scientists, as well as the delivery of superb clinical care, with the overarching goal of improving childhood health. We are home to a diverse group of physicians, nurses, pharmacists, and scientists whose professional interests span across multiple areas of pediatric infectious diseases, including:

Division faculty, staff, and fellows continue to be recognized at Vanderbilt as well as nationally with awards and fellowships for their contributions to research, teaching, and clinical care. Our team is continually at the forefront of research in new and innovative approaches to the diagnosis, treatment, and prevention of pediatric infections. With a multimillion-dollar research funding program, our faculty, staff, and students are daily committed to fundamental and clinical discovery to benefit the health of children. The diversity of our research is impressive in scope, spanning from studies of the molecular basis of bacterial and viral infections and antimicrobial discovery to antibiotic surveillance, vaccine trials, emerging infections countermeasures, and outcomes of treatments in South America and Africa. The division contributed profoundly from 2020 to the present in development of antivirals, vaccines, and clinical management of COVID, as well as to discovery of novel mechanisms of SARS-CoV-2 biology. Our faculty direct and/or have appointments in the Vanderbilt Institute for Global Health, the Vanderbilt Vaccine Center, the Vanderbilt Vaccine Research Program, and the Vanderbilt Institute for Infection, Immunity, and Inflammation.

Education and training are integral to all aspects of our mission. This includes clinical training for residents and medical students, and research training and career development for faculty, fellows, PhD graduate students, postdoctoral scientists, and visiting international scholars. Our faculty and trainees have obtained competitive training grant funding from the National Institutes of Health, national and international private industries, and private foundations. The Division is home to a postdoctoral training grant (T32) in pediatric infectious diseases and multiple NIH individual training grants and career development awards (K12, KL2, K08, K23, F30, F31 and other).

Our student, fellow, and faculty alumni have achieved national and international prominence and leadership positions as Pediatric Infectious Diseases division directors, department chairs, research directors at global pharma companies, NIH and CDC staff and scientists, and academic pediatric infectious diseases physician-scientists.

I invite you to learn more about the division through our website and contact us regarding opportunities for education, training, and collaborations.

Best regards,

Anthony R. Flores, MD, MPH, PhD, FAAP, FPIDS
Director, Division of Pediatric Infectious Diseases
Professor of Pediatrics, Infectious Diseases
Edward Claiborne Stahlman Chair
Vanderbilt University Medical Center